
A single PSA test taken before the age 50 years can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a study by researchers at Memorial Sloan-Kettering Cancer Center in New York and Lund University in Sweden. The findings, published in the online journal BMC Medicine, should help physicians identify men who would benefit from intensive prostate cancer screenings over their lifetime.